" class="no-js "lang="en-US"> Teva Pharmaceuticals - Medtech Alert
Wednesday, March 22, 2023
Teva Pharmaceuticals | Pharmtech Focus

Teva Pharmaceuticals

About Teva Pharmaceuticals

Teva Pharmaceuticals

Teva Pharmaceuticals has been developing and producing medicines to help improve people’s lives for more than a century. We are committed to being a global leader in generic and specialty medicines with a portfolio of 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day. They are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products. Learn more at www.tevapharm.com.

Please note that adverse effects for any of our products should be reported to: Safety.AE@teva.co.il

Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva’s Pharmacovigilance Privacy Policy may be found here:

Related Story

NHS Strikes Deal to Make PKU Drug Available For All

December 17 2021

The NHS is set to make a drug for the rare, debilitating disorder phenylketonuria (PKU) […]

Teva Pharmaceuticals Receives European Approval for Spiromax Inhalers

April 8 2021

Teva Pharmaceuticals announced today that it received European marketing authorization for its Seffalair and BroPair Spiromax […]